| __timestamp | Alpine Immune Sciences, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 1271353000 |
| Thursday, January 1, 2015 | 16054000 | 1620577000 |
| Friday, January 1, 2016 | 23316000 | 2052295000 |
| Sunday, January 1, 2017 | 10626000 | 2075142000 |
| Monday, January 1, 2018 | 28970000 | 2186100000 |
| Tuesday, January 1, 2019 | 35847000 | 3036600000 |
| Wednesday, January 1, 2020 | 27185000 | 2735000000 |
| Friday, January 1, 2021 | 58742000 | 2908100000 |
| Saturday, January 1, 2022 | 70243000 | 3592500000 |
| Sunday, January 1, 2023 | 80904000 | 4439000000 |
| Monday, January 1, 2024 | 5132000000 |
Infusing magic into the data realm
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Regeneron Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc. have demonstrated contrasting trajectories in their R&D investments.
Regeneron has consistently led the charge, with its R&D expenses growing by approximately 250% from 2014 to 2023. This substantial investment underscores Regeneron's dedication to pioneering new treatments and maintaining its position as a leader in the biotech industry.
In contrast, Alpine Immune Sciences has shown a more modest increase in R&D spending, with a growth of around 560% over the same period. While smaller in scale, Alpine's focused investments highlight its strategic approach to developing niche therapies.
This data offers a fascinating glimpse into how these companies prioritize innovation and adapt to the evolving landscape of biotechnology.
R&D Insights: How Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. Allocate Funds
Regeneron Pharmaceuticals, Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Novavax, Inc.
Regeneron Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Comparing Innovation Spending: argenx SE and Alpine Immune Sciences, Inc.
Comparing Innovation Spending: Lantheus Holdings, Inc. and Alpine Immune Sciences, Inc.
Alkermes plc or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Alpine Immune Sciences, Inc. or Catalyst Pharmaceuticals, Inc.: Who Invests More in Innovation?